Brief: UCB Receives U.S. FDA Approval For 320 Mg Single-Injection Device Presentations Of Bimzelx (Bimekizumab-Bkzx)

UCB SA

14/10/2024 06:02

Ucb SA  UCB.BR :
    * UCB RECEIVES U.S. FDA APPROVAL FOR 320 MG SINGLE-INJECTION
DEVICE PRESENTATIONS OF BIMZELX ®  (BIMEKIZUMAB-BKZX)
    * UCB SA - THESE NEW DEVICE PRESENTATIONS WILL BE AVAILABLE
IN
U.S. IN Q1 2025

Source text for Eikon:  ID: 
Further company coverage:  UCB.BR